阿尔尼拉姆制药

Alnylam Pharmaceuticals's 15-min chart shows MACD Death Cross, KDJ Death Cross.

Alnylam Pharmaceuticals' 15min chart shows Bollinger Bands Narrowing, KDJ Death Cross.

Alnylam Pharmaceuticals: RSI Overbought, KDJ Death Cross on 15-minute chart.

Catalyst<ul> <li>Most analysts rate ALNY Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state, and we need to pay attention to the risk of decline.</li> <li>Bearish signals are obviously dominant in the technical indicators.</li> <li>Small, Medium, and Large fund flows show net outflows, suggesting reduced retail and institutional participation.</li></ul>

Key Factors

Alnylam Pharmaceuticals reported mixed earnings and strategic updates, causing its stock to tumble 1.83% despite record revenue in Q1 2025.

ALNY News